Lornoxicam PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified Lornoxicam PCD pharma franchise company offering a portfolio of 6 Lornoxicam formulations. We supply quality-assured, consistently manufactured Lornoxicam products to franchise partners and distributors across India on a monopoly (district-wise) basis.

What is Lornoxicam?

Lornoxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class that inhibits both cyclo-oxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis to produce strong analgesic and anti-inflammatory effects. It is used for the relief of acute pain and inflammation. Reference: PubChem.

Available Forms

Our Lornoxicam range is available as Tablets, allowing partners to serve diverse prescriptions from a single reliable supplier.

Therapeutic Applications of Lornoxicam

Lornoxicam is indicated for acute moderate pain, postoperative and dental pain, and the symptomatic treatment of osteoarthritis and rheumatoid arthritis. It is commonly prescribed by orthopaedicians, rheumatologists, dentists and general physicians.

Why Lornoxicam is a High-Potential Molecule for Distributors

Pain management is one of the highest-volume prescription categories in India, spanning orthopaedics, dentistry and post-surgical care. Lornoxicam offers potent oxicam-class analgesia and is frequently co-formulated with paracetamol or muscle relaxants, giving distributors dependable, high-frequency demand across multiple specialties.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers exclusive monopoly rights, WHO-GMP certified and DCGI-approved formulations, attractive promotional inputs, and the backing of a network of 1000+ franchise partners. Our transparent pricing and dependable supply chain help distributors build a profitable long-term business.

References

1. PubChem - Lornoxicam
2. DrugBank - Lornoxicam
3. PubMed - Lornoxicam research